Eubiologics

Company providing customized services for development and manufacturing biologics from both mammalian cell and microbial-based systems.

placeSeoul, Seoul, South Korea calendar_todayFounded 2012 groups314 employees language eubiologics.com

Innovation

14 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 290 times.

YearFilings
20182
20191
20206
20213
20224
20232
20244
20251
20262

Investor mix

10 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital660%
Private equity220%
Bank & private debt110%
Other / undisclosed110%
Coming soon